BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 1, Issue 1
  • This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Infectious Diseases
ISSN
2220-3176
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial
©2011 Baishideng Publishing Group Co.
World J Clin Infect Dis. Dec 30, 2011; 1(1): 4-10
Published online Dec 30, 2011. doi: 10.5495/wjcid.v1.i1.4
Table 4 Revealed in vitro interactions between statins and non-antifungal drugs against zygomycetous fungi
SpeciesNon-antifungal drugStatinInteractionRef.
Zygomycetes
Absidia corymbiferaSURFLVSYN[35]
Absidia glaucaSURFLVANT[35]
Micromucor ramannianaSURFLVSYN[35]
Mucor circinelloides f. lusitanicusSURFLVADD, SYN[35]
Mucor racemosusSURFLVANT[35]
Mycotypha africanaPAFATO, SIMADD[34]
LOV, ROSADD, SYN[34]
Rhizomucor mieheiiSURFLVANT[35]
Rhizomucor pusillusSURFLVANT[35]
Rhizopus oryzaeSURFLVADD, SYN[35]
Rhizopus schipperaeSURFLVADD, SYN[35]
Saksanaea vasiformisSURFLVADD, SYN[35]
Syncephalastrum racemosumPAFATOADD, SYN[34]
ROS, SIMSYN[34]
SURFLVADD, SYN[35]
ADD: Additive interaction; ANT: Antagonism; ATO: Atorvastatin; FLV: Fluvastatin; LOV: Lovastatin; PAF: Penicillium chrysogenum antifungal protein; ROS: Rosuvastatin; SIM: Simvastatin; SUR: Suramin; SYN: Synergistic interaction.
Full Size Table
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.